BFAR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.974610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.443200E-01
Normal-vs-Stage2
1.453380E-01
Normal-vs-Stage3
5.220000E-01
Normal-vs-Stage4
1.711850E-01
Stage1-vs-Stage2
2.186800E-01
Stage1-vs-Stage3
6.832600E-01
Stage1-vs-Stage4
1.540240E-01
Stage2-vs-Stage3
7.123800E-01
Stage2-vs-Stage4
1.801440E-01
Stage3-vs-Stage4
4.624000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.149200E-01
Normal-vs-AfricanAmerican
4.446600E-01
Normal-vs-Asian
1.550380E-01
Caucasian-vs-AfricanAmerican
3.850800E-01
Caucasian-vs-Asian
7.504800E-01
AfricanAmerican-vs-Asian
2.973200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.163600E-01
Normal-vs-Female
1.886600E-01
Male-vs-Female
8.212200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.575800E-01
Normal-vs-Age(41-60Yrs)
1.413570E-01
Normal-vs-Age(61-80Yrs)
2.400400E-01
Normal-vs-Age(81-100Yrs)
1.136410E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.286200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.414400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.729800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.213800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.962400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.284600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.699000E-01
Normal-vs-Daily Drinker
2.995000E-01
Normal-vs-Weekly Drinker
4.187000E-01
Normal-vs-Occasional Drinker
1.580010E-01
Normal-vs-Social Drinker
1.289820E-01
Non Drinker-vs-Daily Drinker
5.434000E-01
Non Drinker-vs-Weekly Drinker
8.936800E-01
Non Drinker-vs-Occasional Drinker
1.633980E-01
Non Drinker-vs-Social Drinker
8.069000E-01
Daily Drinker-vs-Weekly Drinker
5.838400E-01
Daily Drinker-vs-Occasional Drinker
5.253600E-01
Daily Drinker-vs-Social Drinker
7.127000E-01
Weekly Drinker-vs-Occasional Drinker
2.572400E-01
Weekly Drinker-vs-Social Drinker
7.540600E-01
Occasional Drinker-vs-Social Drinker
2.760200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.534830E-01
Normal-vs-Grade 2
1.280050E-02
Normal-vs-Grade 3
2.031600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.156830E-04
Grade 1-vs-Grade 3
4.776700E-04
Grade 1-vs-Grade 4
1.534830E-01
Grade 2-vs-Grade 3
7.969600E-01
Grade 2-vs-Grade 4
1.280050E-02
Grade 3-vs-Grade 4
2.031600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.096200E-01
Normal-vs-NonDiabetic
1.826210E-01
Diabetic-vs-NonDiabetic
4.437200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.416000E-03
Normal-vs-NoPancreatitis
2.345800E-01
Pancreatitis-vs-NoPancreatitis
3.749700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.870430E-01
Normal-vs-N1
1.766200E-01
N0-vs-N1
5.091800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.346200E-02
Normal-vs-TP53-NonMutant
4.322000E-01
TP53-Mutant-vs-TP53-NonMutant
2.69419999998632E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
